These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 34157187)

  • 1. Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction.
    Saussez S; Sharma S; Thiriard A; Olislagers V; Vu Duc I; Le Bon SD; Khalife M; Hans S; De Riu G; Hopkins C; Lechien JR; Vaira LA; Marchant A
    Eur J Neurol; 2021 Nov; 28(11):3702-3711. PubMed ID: 34157187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics.
    Speth MM; Singer-Cornelius T; Oberle M; Gengler I; Brockmeier SJ; Sedaghat AR
    Otolaryngol Head Neck Surg; 2020 Jul; 163(1):114-120. PubMed ID: 32423357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory-related Quality of Life Adjustments in Smell Loss during the Coronavirus-19 Pandemic.
    Liu DT; Prem B; Besser G; Renner B; Mueller CA
    Am J Rhinol Allergy; 2022 Mar; 36(2):253-260. PubMed ID: 34704454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients.
    Lechien JR; Chiesa-Estomba CM; Vaira LA; De Riu G; Cammaroto G; Chekkoury-Idrissi Y; Circiu M; Distinguin L; Journe F; de Terwangne C; Machayekhi S; Barillari MR; Calvo-Henriquez C; Hans S; Saussez S
    Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):2851-2859. PubMed ID: 33452919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactory Dysfunction: A Highly Prevalent Symptom of COVID-19 With Public Health Significance.
    Sedaghat AR; Gengler I; Speth MM
    Otolaryngol Head Neck Surg; 2020 Jul; 163(1):12-15. PubMed ID: 32366160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-lasting olfactory dysfunction in COVID-19 patients.
    Prem B; Liu DT; Besser G; Sharma G; Dultinger LE; Hofer SV; Matiasczyk MM; Renner B; Mueller CA
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3485-3492. PubMed ID: 34757458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and 24-month recovery of olfactory dysfunction in COVID-19 patients: A multicentre prospective study.
    Lechien JR; Vaira LA; Saussez S
    J Intern Med; 2023 Jan; 293(1):82-90. PubMed ID: 36000469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and meta-analysis protocol examining the clinical characteristics and epidemiological features of olfactory dysfunction (OD) in coronavirus disease 2019 (COVID-19).
    Tan RQ; Li WTV; Shum WZ; Chu SC; Li HL; Shea YF; Chung TW
    Syst Rev; 2021 Mar; 10(1):73. PubMed ID: 33691796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients.
    Vaira LA; Deiana G; Lechien JR; De Vito A; Cossu A; Dettori M; Del Rio A; Saussez S; Madeddu G; Babudieri S; Fois AG; Cocuzza C; Hopkins C; De Riu G; Piana AF
    Laryngoscope; 2021 Oct; 131(10):2312-2318. PubMed ID: 34287905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients.
    Lechien JR; Chiesa-Estomba CM; Beckers E; Mustin V; Ducarme M; Journe F; Marchant A; Jouffe L; Barillari MR; Cammaroto G; Circiu MP; Hans S; Saussez S
    J Intern Med; 2021 Aug; 290(2):451-461. PubMed ID: 33403772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Persistent Olfactory Disorders in Patients With COVID-19: A Psychophysical Case-Control Study With 1-Year Follow-up.
    Vaira LA; Salzano G; Le Bon SD; Maglio A; Petrocelli M; Steffens Y; Ligas E; Maglitto F; Lechien JR; Saussez S; Vatrella A; Salzano FA; Boscolo-Rizzo P; Hopkins C; De Riu G
    Otolaryngol Head Neck Surg; 2022 Jul; 167(1):183-186. PubMed ID: 34813382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immune mechanism of the nasal epithelium in COVID-19-related olfactory dysfunction.
    Chen S; Wang S
    Front Immunol; 2023; 14():1045009. PubMed ID: 37529051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smell loss associated with SARS-CoV-2 is not clinically different from other viruses: a multicenter cohort study.
    Miyake MM; Valera FCP; Martins RB; Compagnoni IM; Fantucci MZ; Murashima AAB; da Silva LECM; de Lima TM; de Souza MVO; Melo SR; Dolci RLL; Floriano CG; de Campos CAC; Nakanishi M; Freire GSM; Valente AL; Fornazieri MA; da Silva JLB; Anzolin LK; Issa MJA; Souza TV; Lima BA; SantAnna GD; Abreu CB; Sakano E; Cassettari AJ; Avelino MAG; Goncalves MC; de Camargo LA; Romano FR; Alves RD; Roithmann R; Redeker NK; Filho LLB; Dassi CS; Meurer ATO; Garcia DM; Aragon DC; Tepedino MS; Succar ACS; Vianna PM; Dos Santos MCJ; Filho RHR; Kosugi EM; Villa JF; Gregorio LL; Piltcher OB; Meotti CD; Tamashiro E; Arruda E; Anselmo Lima WT
    Rhinology; 2024 Feb; 62(1):55-62. PubMed ID: 37772802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal antibody response and SARS-CoV-2 shedding in patients with COVID-19 related olfactory dysfunction.
    Sharma S; Thiriard A; Olislagers V; Lechien JR; Jurion MH; Delforge ML; Marchant A; Saussez S
    J Med Virol; 2024 Jan; 96(1):e29398. PubMed ID: 38235905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phantosmia May Predict Long-Term Measurable Olfactory Dysfunction After COVID-19.
    Leung JS; Cordano VP; Fuentes-López E; Lagos AE; García-Huidobro FG; Aliaga R; Díaz LA; García-Salum T; Salinas E; Toro A; Callejas CA; Riquelme A; Palmer JN; Medina RA; González G C
    Laryngoscope; 2022 Dec; 132(12):2445-2452. PubMed ID: 36149773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural trajectory of recovery of COVID-19 associated olfactory loss.
    Khan AM; Lee J; Rammaha T; Gupta S; Smith H; Kannampallil T; Farrell N; Kallogjeri D; Piccirillo JF
    Am J Otolaryngol; 2022; 43(5):103572. PubMed ID: 35969913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Effects on Psychophysical Olfactory Scores: Prospective Study With Evaluation Before and 60-Days After Infection.
    Vaira LA; Lechien JR; Salzano G; Maglitto F; Boscolo-Rizzo P; Hopkins C; De Riu G
    Otolaryngol Head Neck Surg; 2023 May; 168(5):1249-1252. PubMed ID: 36821798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Prognostic Factors Associated with Early Recovery of Olfactory Dysfunction in COVID-19 Patients.
    Kreesaeng P; Tangbumrungtham N; Rachapattayakhom R; Roongpuvapaht B; Tanjararak K
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):68S-75S. PubMed ID: 37743845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory Dysfunction in COVID-19 Patients: Prevalence and Prognosis for Recovering Sense of Smell.
    D'Ascanio L; Pandolfini M; Cingolani C; Latini G; Gradoni P; Capalbo M; Frausini G; Maranzano M; Brenner MJ; Di Stadio A
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):82-86. PubMed ID: 32662745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study.
    Mercier J; Osman M; Bouiller K; Tipirdamaz C; Gendrin V; Chirouze C; Lepiller Q; Bouvier E; Royer PY; Pierron A; Toko L; Plantin J; Kadiane-Oussou NJ; Zayet S; Klopfenstein T
    J Med Virol; 2022 Oct; 94(10):4762-4775. PubMed ID: 35672249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.